BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16958785)

  • 1. Effect of ofloxacin on theophylline pharmacokinetics at clinical dosage in dogs.
    Regmi NL; Abd El-Aty AM; Kubota R; Tomita A; Shimoda M
    J Vet Pharmacol Ther; 2006 Oct; 29(5):403-8. PubMed ID: 16958785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of several fluoroquinolones on hepatic microsomal cytochrome P-450 1A activities in dogs.
    Regmi NL; Abd El-Aty AM; Kuroha M; Nakamura M; Shimoda M
    J Vet Pharmacol Ther; 2005 Dec; 28(6):553-7. PubMed ID: 16343288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of inhibitory effects of several fluoroquinolones on cytochrome P-450 3A activities at clinical dosage in dogs.
    Regmi NL; Abd El-Aty AM; Kubota R; Shah SS; Shimoda M
    J Vet Pharmacol Ther; 2007 Feb; 30(1):37-42. PubMed ID: 17217399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
    Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ofloxacin in broiler chicken.
    Kalaiselvi L; Sriranjani D; Ramesh S; Sriram P; Mathuram LN
    J Vet Pharmacol Ther; 2006 Jun; 29(3):185-9. PubMed ID: 16669862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-drug interactions affecting fluoroquinolones.
    Wijnands GJ; Vree TB; Janssen TJ; Guelen PJ
    Am J Med; 1989 Dec; 87(6C):47S-51S. PubMed ID: 2603893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
    Ding HZ; Yang GX; Huang XH; Chen ZL; Zeng ZL
    J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
    Boothe DM; Perkins J
    J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of enoxacin, ofloxacin and norfloxacin on theophylline disposition in humans.
    Sano M; Kawakatsu K; Ohkita C; Yamamoto I; Takeyama M; Yamashina H; Goto M
    Eur J Clin Pharmacol; 1988; 35(2):161-5. PubMed ID: 3191935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
    Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
    Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular spectroscopy and chemometrics: an analytical study of synergistic effects of drugs--interaction between fluoroquinolones and DNA.
    Ni Y; Du S; Kokot S
    Analyst; 2009 Sep; 134(9):1840-7. PubMed ID: 19684908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
    Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
    J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3-dimethyluric acid, after intravenous and oral administration of aminophylline to rats.
    Choi HD; Kang HE; Chung HJ; Bae SK; Shin KN; Lee MG
    Biopharm Drug Dispos; 2007 Nov; 28(8):445-54. PubMed ID: 17847127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of erythromycin after the administration of intravenous and various oral dosage forms to dogs.
    Albarellos GA; Kreil VE; Ambros LA; Waxman S; Montoya L; Tarragona L; Quaine PC; Hallu RE; Rebuelto M
    J Vet Pharmacol Ther; 2008 Dec; 31(6):496-500. PubMed ID: 19000270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of zonisamide and drug interaction with phenobarbital in dogs.
    Orito K; Saito M; Fukunaga K; Matsuo E; Takikawa S; Muto M; Mishima K; Egashira N; Fujiwara M
    J Vet Pharmacol Ther; 2008 Jun; 31(3):259-64. PubMed ID: 18471148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU.
    Yang KH; Lee JH; Lee MG
    J Pharm Pharmacol; 2008 Jan; 60(1):45-53. PubMed ID: 18088504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the pharmacokinetic disposition of levofloxacin in stallions after intravenous and intramuscular administration.
    Goudah A; Abo El-Sooud K; Shim JH; Shin HC; Abd El-Aty AM
    J Vet Pharmacol Ther; 2008 Oct; 31(5):399-405. PubMed ID: 19000258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of levofloxacin after single and multiple oral doses in patients undergoing intermittent haemodialysis.
    Tsaganos T; Kouki P; Digenis P; Giamarellou H; Giamarellos-Bourboulis EJ; Kanellakopoulou K
    Int J Antimicrob Agents; 2008 Jul; 32(1):46-9. PubMed ID: 18534825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.